The FTD™ SARS-CoV-2/FluA/FluB/HRSV Assay*, for use on the VERSANT® kPCR Molecular System, is a semi-automated reverse-transcription real-time PCR assay for in-vitro qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; ORF1ab and N genes), influenza A virus (IAV), influenza B virus (IBV), and human respiratory syncytial virus A and B (HRSV A/B) RNA in nasopharyngeal swab specimens in a viral transport medium obtained from individuals with signs and symptoms of respiratory infections. The test is intended as an aid in the differential diagnosis of SARS-CoV-2, IAV, IBV, and HRSV A/B in humans.
![FTD SARS-CoV-2/FluA/FluB/HRSV Assay](https://marketing.webassets.siemens-healthineers.com/28b3981841ffc32b/6d9776f1bbbe/v/d93b605803c2/ftd-sars-cov-2-flua-flub-hrsv-assay.jpg)
FTD SARS-CoV-2/
FluA/FluB/HRSV Assay
For the detection of five respiratory viruses from one sample eluate: SARS-CoV-2, Influenza A virus, Influenza B virus, and human Respiratory Syncytial Viruses A/B.
FluA/FluB/HRSV Assay
New analysis confirms Siemens Healthineers PCR influenza assays detect new H3N2 influenza strain exhibiting genetic drifts.†
The influenza A assay included in the FTD SARS-CoV-2/FluA/FluB/HRSV Assay*, FTD Respiratory pathogens 21 Assay*, and FTD FLU/HRSV Assay*, detects the new H3N2 strain exhibiting genetic drifts.
†Data on file at Fast Track Diagnostics Luxembourg S.à r.l., a Siemens Healthineers Company. Data is current as of date 30th November 2022.
Pomohly vám tyto informace?
* CE-IVD labeled for diagnostic use in the EU.
All associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.